Global Erythropoietin Drugs Market By Drug Class (Biologics and Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and others), By Application (Renal Diseases, Cancer, Hematology and Neurology), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

The Global Erythropoietin Drugs Market size is expected to reach $20.2 billion by 2027, rising at a market growth of 11.8% CAGR during the forecast period. Erythropoietin (EPO) also called hematopoietin is a glycoprotein hormone. It stimulates the process of erythropoiesis which results in the production of red blood cells in the bone marrow. The main goal for the development of erythropoietin drug was to treat anaemic conditions arising from end-stage renal disease (ESRD) disease. Thus, it helps in treatments of this disease and dialysis procedures. Apart from its use in ESRD anaemic conditions, erythropoietin drugs also received approvals for chemotherapy-induced anaemia. The post-abbreviated new drug application (ANDA) is getting approvals and there is a high success rate of erythropoietin drugs in chemotherapy-induced anaemia. Due to all these factors, major biopharmaceutical companies turned their focus towards another form of induced anaemia, that is ART-induced anaemia which occurs mostly among the HIV patients.

Epoetin alfa (Epoge) is a kind of recombinant erythropoietin that was developed by Amgen Inc. in 1983. It was the first rhEPO that was commercialized in the United States, after alfa and beta formulations. Epoetin refers to an erythropoiesis-stimulating glycoprotein that is composed of a 165-amino acid. It is produced in cell culture based on recombinant DNA technology. This drug is used to treat patients suffering from anaemia and other blood-related clinical conditions like chronic renal failure, chemotherapy, and antiviral drug therapy. This drug is also recommended for patients who are at high risk for perioperative blood loss due to surgical procedures.

COVID-19 Impact Analysis

The COVID-19 resulted in the disruption of workflows in the health care sector across the world. A number of industries were forced to go for shutdown temporarily due to this outbreak. The main affected industry is the sub-domains of health care. Yet, it has positively affected the demand for medicines and increased the demand for several medical services, such as erythropoietin. The erythropoietin (EPO) drug is used to treat anaemia and works effectively against COVID-19. This has been scientifically proved by scientists of the Max Planck Institute of Experimental Medicine in Gottingen. According to the research, the SARS-CoV-2 potentially attacks the brain, and erythropoietin can diminish serious disease development. Thus, it can protect people from the development of long-term neurological problems.

However, EPO is beneficial in many other diseases and has cytoprotective effects such as regenerative, anti-ischemic, and anti-apoptotic effects in tissues like lung, kidney, cardiac muscle, retina, pancreas, nervous system, and endothelial cells. Therefore, the impact of the COVID-19 pandemic is likely to have a positive impact on the erythropoietin drug market.

Drug Class Outlook

Based on Drug Class, the market is segmented into Biologics and Biosimilars. Based on Drug Class, the biologics erythropoietin segment dominated the market in 2020 because of the patent protection. Other factors driving the growth of this segment include the presence of a large patient population and increased uptake of biologics in various diseases. The availability of very few biologics in the market resulted in higher adoption of this drug.

Product Outlook

Based on Product, the market is segmented into Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and others. Epoetin-beta is a recombinant type of drug formed from epoetin-alfa. This product segment is growing owing to its benefits like improved efficacy and a longer half-life compared to the epoetin-alfa. Darbepoetin-alfa is also a novel erythropoietin drug. It is developed by Amgen, Inc., marketed under the brand name Aranesp. Darbepoetin-alfa segment is likely to see positive growth during the forecast period. It is accredited to its higher efficacy, cost-effectiveness, and longer half-life. It is considered a feasible solution for the treatment of anaemia arising due to end-stage renal diseases.

Application Outlook

Based on Application, the market is segmented into Renal Diseases, Cancer, Hematology and Neurology. The cancer segment would showcase fastest growth rate during the forecast period. It is due to the increasing cases of cancer incidence across the world. Cancer chemotherapy includes the utilization of medication which is capable of increasing the RBC count amongst patients. Thus, the usage of such drugs for chemotherapy has gained considerable attention in recent years. This has increased the demand for EPO drugs for cancer treatment that will act as a positive factor to augment the growth of this segment.

Erythropoietin Drugs Market Report Coverage

Report Attribute	Details
Market size value in 2020	USD 8.7 Billion
Market size forecast in 2027	USD 20.2 Billion
Base Year	2020
Historical Period	2017 to 2019
Forecast Period	2021 to 2027
Revenue Growth Rate	CAGR of 11.8% from 2021 to 2027
Number of Pages	195
Number of Tables	360
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Drug Class, Product, Application, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Rising incidences of chronic diseases Increasing usage of erythropoietin drugs in the treatment of anaemia
Restraints	High cost of the erythropoietin drug

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America emerged as one of the dominating regions of the global market by. It is accredited to the factors like the increasing incidence of chronic diseases including cancer, CKD, and HIV. As per data by the Centers for Disease Control and Prevention (CDC), there are 1.2 million people in the U.S. who are living with HIV and more than 39,000 cases were detected in 2015. These statistics are a clear indication that the demand for EPO drugs will increase over the forecast period.

Free Valuable Insights: Global Erythropoietin Drugs Market size to reach USD 20.2 Billion by 2027

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., F. Hoffmann-La Roche Ltd., Biocon Limited, Intas Pharmaceutical Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., LG Corporation (LG Life Sciences Ltd.), and Celltrion, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Drug Class

• Biologics
• Biosimilars

By Product

• Epoetin-alfa
• Epoetin-beta
• Darbepoetin-alfa
• others

By Application

• Renal Diseases
• Cancer
• Hematology
• Neurology

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Johnson and Johnson
• Teva Pharmaceuticals Industries Ltd.
• Amgen, Inc.
• F. Hoffmann-La Roche Ltd.
• Biocon Limited
• Intas Pharmaceutical Ltd.
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy’s Laboratories Ltd.
• LG Corporation (LG Life Sciences Ltd.)
• Celltrion, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Erythropoietin Drugs Market, by Drug Class
1.4.2 Global Erythropoietin Drugs Market, by Product
1.4.3 Global Erythropoietin Drugs Market, by Application
1.4.4 Global Erythropoietin Drugs Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Erythropoietin Drugs Market by Drug Class
3.1 Global Biologics Market by Region
3.2 Global Biosimilars Market by Region

Chapter 4. Global Erythropoietin Drugs Market by Product
4.1 Global Epoetin-alfa Market by Region
4.2 Global Epoetin-beta Market by Region
4.3 Global Darbepoetin-alfa Market by Region
4.4 Global Other Product Market by Region

Chapter 5. Global Erythropoietin Drugs Market by Application
5.1 Global Renal Diseases Market by Region
5.2 Global Cancer Market by Region
5.3 Global Hematology Market by Region
5.4 Global Neurology Market by Region

Chapter 6. Global Erythropoietin Drugs Market by Region
6.1 North America Erythropoietin Drugs Market
6.1.1 North America Erythropoietin Drugs Market by Drug Class
6.1.1.1 North America Biologics Market by Country
6.1.1.2 North America Biosimilars Market by Country
6.1.2 North America Erythropoietin Drugs Market by Product
6.1.2.1 North America Epoetin-alfa Market by Country
6.1.2.2 North America Epoetin-beta Market by Country
6.1.2.3 North America Darbepoetin-alfa Market by Country
6.1.2.4 North America Other Product Market by Country
6.1.3 North America Erythropoietin Drugs Market by Application
6.1.3.1 North America Renal Diseases Market by Country
6.1.3.2 North America Cancer Market by Country
6.1.3.3 North America Hematology Market by Country
6.1.3.4 North America Neurology Market by Country
6.1.4 North America Erythropoietin Drugs Market by Country
6.1.4.1 US Erythropoietin Drugs Market
6.1.4.1.1 US Erythropoietin Drugs Market by Drug Class
6.1.4.1.2 US Erythropoietin Drugs Market by Product
6.1.4.1.3 US Erythropoietin Drugs Market by Application
6.1.4.2 Canada Erythropoietin Drugs Market
6.1.4.2.1 Canada Erythropoietin Drugs Market by Drug Class
6.1.4.2.2 Canada Erythropoietin Drugs Market by Product
6.1.4.2.3 Canada Erythropoietin Drugs Market by Application
6.1.4.3 Mexico Erythropoietin Drugs Market
6.1.4.3.1 Mexico Erythropoietin Drugs Market by Drug Class
6.1.4.3.2 Mexico Erythropoietin Drugs Market by Product
6.1.4.3.3 Mexico Erythropoietin Drugs Market by Application
6.1.4.4 Rest of North America Erythropoietin Drugs Market
6.1.4.4.1 Rest of North America Erythropoietin Drugs Market by Drug Class
6.1.4.4.2 Rest of North America Erythropoietin Drugs Market by Product
6.1.4.4.3 Rest of North America Erythropoietin Drugs Market by Application
6.2 Europe Erythropoietin Drugs Market
6.2.1 Europe Erythropoietin Drugs Market by Drug Class
6.2.1.1 Europe Biologics Market by Country
6.2.1.2 Europe Biosimilars Market by Country
6.2.2 Europe Erythropoietin Drugs Market by Product
6.2.2.1 Europe Epoetin-alfa Market by Country
6.2.2.2 Europe Epoetin-beta Market by Country
6.2.2.3 Europe Darbepoetin-alfa Market by Country
6.2.2.4 Europe Other Product Market by Country
6.2.3 Europe Erythropoietin Drugs Market by Application
6.2.3.1 Europe Renal Diseases Market by Country
6.2.3.2 Europe Cancer Market by Country
6.2.3.3 Europe Hematology Market by Country
6.2.3.4 Europe Neurology Market by Country
6.2.4 Europe Erythropoietin Drugs Market by Country
6.2.4.1 Germany Erythropoietin Drugs Market
6.2.4.1.1 Germany Erythropoietin Drugs Market by Drug Class
6.2.4.1.2 Germany Erythropoietin Drugs Market by Product
6.2.4.1.3 Germany Erythropoietin Drugs Market by Application
6.2.4.2 UK Erythropoietin Drugs Market
6.2.4.2.1 UK Erythropoietin Drugs Market by Drug Class
6.2.4.2.2 UK Erythropoietin Drugs Market by Product
6.2.4.2.3 UK Erythropoietin Drugs Market by Application
6.2.4.3 France Erythropoietin Drugs Market
6.2.4.3.1 France Erythropoietin Drugs Market by Drug Class
6.2.4.3.2 France Erythropoietin Drugs Market by Product
6.2.4.3.3 France Erythropoietin Drugs Market by Application
6.2.4.4 Russia Erythropoietin Drugs Market
6.2.4.4.1 Russia Erythropoietin Drugs Market by Drug Class
6.2.4.4.2 Russia Erythropoietin Drugs Market by Product
6.2.4.4.3 Russia Erythropoietin Drugs Market by Application
6.2.4.5 Spain Erythropoietin Drugs Market
6.2.4.5.1 Spain Erythropoietin Drugs Market by Drug Class
6.2.4.5.2 Spain Erythropoietin Drugs Market by Product
6.2.4.5.3 Spain Erythropoietin Drugs Market by Application
6.2.4.6 Italy Erythropoietin Drugs Market
6.2.4.6.1 Italy Erythropoietin Drugs Market by Drug Class
6.2.4.6.2 Italy Erythropoietin Drugs Market by Product
6.2.4.6.3 Italy Erythropoietin Drugs Market by Application
6.2.4.7 Rest of Europe Erythropoietin Drugs Market
6.2.4.7.1 Rest of Europe Erythropoietin Drugs Market by Drug Class
6.2.4.7.2 Rest of Europe Erythropoietin Drugs Market by Product
6.2.4.7.3 Rest of Europe Erythropoietin Drugs Market by Application
6.3 Asia Pacific Erythropoietin Drugs Market
6.3.1 Asia Pacific Erythropoietin Drugs Market by Drug Class
6.3.1.1 Asia Pacific Biologics Market by Country
6.3.1.2 Asia Pacific Biosimilars Market by Country
6.3.2 Asia Pacific Erythropoietin Drugs Market by Product
6.3.2.1 Asia Pacific Epoetin-alfa Market by Country
6.3.2.2 Asia Pacific Epoetin-beta Market by Country
6.3.2.3 Asia Pacific Darbepoetin-alfa Market by Country
6.3.2.4 Asia Pacific Other Product Market by Country
6.3.3 Asia Pacific Erythropoietin Drugs Market by Application
6.3.3.1 Asia Pacific Renal Diseases Market by Country
6.3.3.2 Asia Pacific Cancer Market by Country
6.3.3.3 Asia Pacific Hematology Market by Country
6.3.3.4 Asia Pacific Neurology Market by Country
6.3.4 Asia Pacific Erythropoietin Drugs Market by Country
6.3.4.1 China Erythropoietin Drugs Market
6.3.4.1.1 China Erythropoietin Drugs Market by Drug Class
6.3.4.1.2 China Erythropoietin Drugs Market by Product
6.3.4.1.3 China Erythropoietin Drugs Market by Application
6.3.4.2 Japan Erythropoietin Drugs Market
6.3.4.2.1 Japan Erythropoietin Drugs Market by Drug Class
6.3.4.2.2 Japan Erythropoietin Drugs Market by Product
6.3.4.2.3 Japan Erythropoietin Drugs Market by Application
6.3.4.3 India Erythropoietin Drugs Market
6.3.4.3.1 India Erythropoietin Drugs Market by Drug Class
6.3.4.3.2 India Erythropoietin Drugs Market by Product
6.3.4.3.3 India Erythropoietin Drugs Market by Application
6.3.4.4 South Korea Erythropoietin Drugs Market
6.3.4.4.1 South Korea Erythropoietin Drugs Market by Drug Class
6.3.4.4.2 South Korea Erythropoietin Drugs Market by Product
6.3.4.4.3 South Korea Erythropoietin Drugs Market by Application
6.3.4.5 Singapore Erythropoietin Drugs Market
6.3.4.5.1 Singapore Erythropoietin Drugs Market by Drug Class
6.3.4.5.2 Singapore Erythropoietin Drugs Market by Product
6.3.4.5.3 Singapore Erythropoietin Drugs Market by Application
6.3.4.6 Malaysia Erythropoietin Drugs Market
6.3.4.6.1 Malaysia Erythropoietin Drugs Market by Drug Class
6.3.4.6.2 Malaysia Erythropoietin Drugs Market by Product
6.3.4.6.3 Malaysia Erythropoietin Drugs Market by Application
6.3.4.7 Rest of Asia Pacific Erythropoietin Drugs Market
6.3.4.7.1 Rest of Asia Pacific Erythropoietin Drugs Market by Drug Class
6.3.4.7.2 Rest of Asia Pacific Erythropoietin Drugs Market by Product
6.3.4.7.3 Rest of Asia Pacific Erythropoietin Drugs Market by Application
6.4 LAMEA Erythropoietin Drugs Market
6.4.1 LAMEA Erythropoietin Drugs Market by Drug Class
6.4.1.1 LAMEA Biologics Market by Country
6.4.1.2 LAMEA Biosimilars Market by Country
6.4.2 LAMEA Erythropoietin Drugs Market by Product
6.4.2.1 LAMEA Epoetin-alfa Market by Country
6.4.2.2 LAMEA Epoetin-beta Market by Country
6.4.2.3 LAMEA Darbepoetin-alfa Market by Country
6.4.2.4 LAMEA Other Product Market by Country
6.4.3 LAMEA Erythropoietin Drugs Market by Application
6.4.3.1 LAMEA Renal Diseases Market by Country
6.4.3.2 LAMEA Cancer Market by Country
6.4.3.3 LAMEA Hematology Market by Country
6.4.3.4 LAMEA Neurology Market by Country
6.4.4 LAMEA Erythropoietin Drugs Market by Country
6.4.4.1 Brazil Erythropoietin Drugs Market
6.4.4.1.1 Brazil Erythropoietin Drugs Market by Drug Class
6.4.4.1.2 Brazil Erythropoietin Drugs Market by Product
6.4.4.1.3 Brazil Erythropoietin Drugs Market by Application
6.4.4.2 Argentina Erythropoietin Drugs Market
6.4.4.2.1 Argentina Erythropoietin Drugs Market by Drug Class
6.4.4.2.2 Argentina Erythropoietin Drugs Market by Product
6.4.4.2.3 Argentina Erythropoietin Drugs Market by Application
6.4.4.3 UAE Erythropoietin Drugs Market
6.4.4.3.1 UAE Erythropoietin Drugs Market by Drug Class
6.4.4.3.2 UAE Erythropoietin Drugs Market by Product
6.4.4.3.3 UAE Erythropoietin Drugs Market by Application
6.4.4.4 Saudi Arabia Erythropoietin Drugs Market
6.4.4.4.1 Saudi Arabia Erythropoietin Drugs Market by Drug Class
6.4.4.4.2 Saudi Arabia Erythropoietin Drugs Market by Product
6.4.4.4.3 Saudi Arabia Erythropoietin Drugs Market by Application
6.4.4.5 South Africa Erythropoietin Drugs Market
6.4.4.5.1 South Africa Erythropoietin Drugs Market by Drug Class
6.4.4.5.2 South Africa Erythropoietin Drugs Market by Product
6.4.4.5.3 South Africa Erythropoietin Drugs Market by Application
6.4.4.6 Nigeria Erythropoietin Drugs Market
6.4.4.6.1 Nigeria Erythropoietin Drugs Market by Drug Class
6.4.4.6.2 Nigeria Erythropoietin Drugs Market by Product
6.4.4.6.3 Nigeria Erythropoietin Drugs Market by Application
6.4.4.7 Rest of LAMEA Erythropoietin Drugs Market
6.4.4.7.1 Rest of LAMEA Erythropoietin Drugs Market by Drug Class
6.4.4.7.2 Rest of LAMEA Erythropoietin Drugs Market by Product
6.4.4.7.3 Rest of LAMEA Erythropoietin Drugs Market by Application

Chapter 7. Company Profiles
7.1 Johnson and Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals:
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Amgen, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.1 Financial Analysis
7.4.2 Segmental and Regional Analysis
7.4.3 Research & Development Expense
7.5 Biocon Limited
7.5.1 Company Overview
7.6 Intas Pharmaceutical Ltd.
7.6.1 Company Overview
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Dr. Reddy’s Laboratories Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 LG Corporation (LG Life Sciences Ltd.)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.10. Celltrion, Inc.
7.10.1 Company Overview

TABLE 1 Global Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 2 Global Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 3 Global Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 4 Global Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 5 Global Biologics Market by Region, 2017 - 2020, USD Million
TABLE 6 Global Biologics Market by Region, 2021 - 2027, USD Million
TABLE 7 Global Biosimilars Market by Region, 2017 - 2020, USD Million
TABLE 8 Global Biosimilars Market by Region, 2021 - 2027, USD Million
TABLE 9 Global Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 10 Global Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 11 Global Epoetin-alfa Market by Region, 2017 - 2020, USD Million
TABLE 12 Global Epoetin-alfa Market by Region, 2021 - 2027, USD Million
TABLE 13 Global Epoetin-beta Market by Region, 2017 - 2020, USD Million
TABLE 14 Global Epoetin-beta Market by Region, 2021 - 2027, USD Million
TABLE 15 Global Darbepoetin-alfa Market by Region, 2017 - 2020, USD Million
TABLE 16 Global Darbepoetin-alfa Market by Region, 2021 - 2027, USD Million
TABLE 17 Global Other Product Market by Region, 2017 - 2020, USD Million
TABLE 18 Global Other Product Market by Region, 2021 - 2027, USD Million
TABLE 19 Global Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 20 Global Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 21 Global Renal Diseases Market by Region, 2017 - 2020, USD Million
TABLE 22 Global Renal Diseases Market by Region, 2021 - 2027, USD Million
TABLE 23 Global Cancer Market by Region, 2017 - 2020, USD Million
TABLE 24 Global Cancer Market by Region, 2021 - 2027, USD Million
TABLE 25 Global Hematology Market by Region, 2017 - 2020, USD Million
TABLE 26 Global Hematology Market by Region, 2021 - 2027, USD Million
TABLE 27 Global Neurology Market by Region, 2017 - 2020, USD Million
TABLE 28 Global Neurology Market by Region, 2021 - 2027, USD Million
TABLE 29 Global Erythropoietin Drugs Market by Region, 2017 - 2020, USD Million
TABLE 30 Global Erythropoietin Drugs Market by Region, 2021 - 2027, USD Million
TABLE 31 North America Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 32 North America Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 33 North America Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 34 North America Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 35 North America Biologics Market by Country, 2017 - 2020, USD Million
TABLE 36 North America Biologics Market by Country, 2021 - 2027, USD Million
TABLE 37 North America Biosimilars Market by Country, 2017 - 2020, USD Million
TABLE 38 North America Biosimilars Market by Country, 2021 - 2027, USD Million
TABLE 39 North America Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 40 North America Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 41 North America Epoetin-alfa Market by Country, 2017 - 2020, USD Million
TABLE 42 North America Epoetin-alfa Market by Country, 2021 - 2027, USD Million
TABLE 43 North America Epoetin-beta Market by Country, 2017 - 2020, USD Million
TABLE 44 North America Epoetin-beta Market by Country, 2021 - 2027, USD Million
TABLE 45 North America Darbepoetin-alfa Market by Country, 2017 - 2020, USD Million
TABLE 46 North America Darbepoetin-alfa Market by Country, 2021 - 2027, USD Million
TABLE 47 North America Other Product Market by Country, 2017 - 2020, USD Million
TABLE 48 North America Other Product Market by Country, 2021 - 2027, USD Million
TABLE 49 North America Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 50 North America Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 51 North America Renal Diseases Market by Country, 2017 - 2020, USD Million
TABLE 52 North America Renal Diseases Market by Country, 2021 - 2027, USD Million
TABLE 53 North America Cancer Market by Country, 2017 - 2020, USD Million
TABLE 54 North America Cancer Market by Country, 2021 - 2027, USD Million
TABLE 55 North America Hematology Market by Country, 2017 - 2020, USD Million
TABLE 56 North America Hematology Market by Country, 2021 - 2027, USD Million
TABLE 57 North America Neurology Market by Country, 2017 - 2020, USD Million
TABLE 58 North America Neurology Market by Country, 2021 - 2027, USD Million
TABLE 59 North America Erythropoietin Drugs Market by Country, 2017 - 2020, USD Million
TABLE 60 North America Erythropoietin Drugs Market by Country, 2021 - 2027, USD Million
TABLE 61 US Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 62 US Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 63 US Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 64 US Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 65 US Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 66 US Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 67 US Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 68 US Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 69 Canada Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 70 Canada Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 71 Canada Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 72 Canada Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 73 Canada Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 74 Canada Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 75 Canada Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 76 Canada Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 77 Mexico Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 78 Mexico Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 79 Mexico Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 80 Mexico Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 81 Mexico Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 82 Mexico Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 83 Mexico Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 84 Mexico Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 85 Rest of North America Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 86 Rest of North America Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 87 Rest of North America Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 88 Rest of North America Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 89 Rest of North America Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 90 Rest of North America Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 91 Rest of North America Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 92 Rest of North America Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 93 Europe Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 94 Europe Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 95 Europe Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 96 Europe Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 97 Europe Biologics Market by Country, 2017 - 2020, USD Million
TABLE 98 Europe Biologics Market by Country, 2021 - 2027, USD Million
TABLE 99 Europe Biosimilars Market by Country, 2017 - 2020, USD Million
TABLE 100 Europe Biosimilars Market by Country, 2021 - 2027, USD Million
TABLE 101 Europe Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 102 Europe Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 103 Europe Epoetin-alfa Market by Country, 2017 - 2020, USD Million
TABLE 104 Europe Epoetin-alfa Market by Country, 2021 - 2027, USD Million
TABLE 105 Europe Epoetin-beta Market by Country, 2017 - 2020, USD Million
TABLE 106 Europe Epoetin-beta Market by Country, 2021 - 2027, USD Million
TABLE 107 Europe Darbepoetin-alfa Market by Country, 2017 - 2020, USD Million
TABLE 108 Europe Darbepoetin-alfa Market by Country, 2021 - 2027, USD Million
TABLE 109 Europe Other Product Market by Country, 2017 - 2020, USD Million
TABLE 110 Europe Other Product Market by Country, 2021 - 2027, USD Million
TABLE 111 Europe Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 112 Europe Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 113 Europe Renal Diseases Market by Country, 2017 - 2020, USD Million
TABLE 114 Europe Renal Diseases Market by Country, 2021 - 2027, USD Million
TABLE 115 Europe Cancer Market by Country, 2017 - 2020, USD Million
TABLE 116 Europe Cancer Market by Country, 2021 - 2027, USD Million
TABLE 117 Europe Hematology Market by Country, 2017 - 2020, USD Million
TABLE 118 Europe Hematology Market by Country, 2021 - 2027, USD Million
TABLE 119 Europe Neurology Market by Country, 2017 - 2020, USD Million
TABLE 120 Europe Neurology Market by Country, 2021 - 2027, USD Million
TABLE 121 Europe Erythropoietin Drugs Market by Country, 2017 - 2020, USD Million
TABLE 122 Europe Erythropoietin Drugs Market by Country, 2021 - 2027, USD Million
TABLE 123 Germany Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 124 Germany Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 125 Germany Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 126 Germany Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 127 Germany Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 128 Germany Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 129 Germany Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 130 Germany Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 131 UK Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 132 UK Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 133 UK Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 134 UK Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 135 UK Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 136 UK Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 137 UK Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 138 UK Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 139 France Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 140 France Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 141 France Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 142 France Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 143 France Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 144 France Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 145 France Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 146 France Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 147 Russia Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 148 Russia Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 149 Russia Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 150 Russia Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 151 Russia Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 152 Russia Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 153 Russia Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 154 Russia Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 155 Spain Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 156 Spain Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 157 Spain Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 158 Spain Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 159 Spain Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 160 Spain Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 161 Spain Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 162 Spain Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 163 Italy Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 164 Italy Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 165 Italy Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 166 Italy Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 167 Italy Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 168 Italy Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 169 Italy Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 170 Italy Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 171 Rest of Europe Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 172 Rest of Europe Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 173 Rest of Europe Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 174 Rest of Europe Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 175 Rest of Europe Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 176 Rest of Europe Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 177 Rest of Europe Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 178 Rest of Europe Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 179 Asia Pacific Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 180 Asia Pacific Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 181 Asia Pacific Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 182 Asia Pacific Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 183 Asia Pacific Biologics Market by Country, 2017 - 2020, USD Million
TABLE 184 Asia Pacific Biologics Market by Country, 2021 - 2027, USD Million
TABLE 185 Asia Pacific Biosimilars Market by Country, 2017 - 2020, USD Million
TABLE 186 Asia Pacific Biosimilars Market by Country, 2021 - 2027, USD Million
TABLE 187 Asia Pacific Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 188 Asia Pacific Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 189 Asia Pacific Epoetin-alfa Market by Country, 2017 - 2020, USD Million
TABLE 190 Asia Pacific Epoetin-alfa Market by Country, 2021 - 2027, USD Million
TABLE 191 Asia Pacific Epoetin-beta Market by Country, 2017 - 2020, USD Million
TABLE 192 Asia Pacific Epoetin-beta Market by Country, 2021 - 2027, USD Million
TABLE 193 Asia Pacific Darbepoetin-alfa Market by Country, 2017 - 2020, USD Million
TABLE 194 Asia Pacific Darbepoetin-alfa Market by Country, 2021 - 2027, USD Million
TABLE 195 Asia Pacific Other Product Market by Country, 2017 - 2020, USD Million
TABLE 196 Asia Pacific Other Product Market by Country, 2021 - 2027, USD Million
TABLE 197 Asia Pacific Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 198 Asia Pacific Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 199 Asia Pacific Renal Diseases Market by Country, 2017 - 2020, USD Million
TABLE 200 Asia Pacific Renal Diseases Market by Country, 2021 - 2027, USD Million
TABLE 201 Asia Pacific Cancer Market by Country, 2017 - 2020, USD Million
TABLE 202 Asia Pacific Cancer Market by Country, 2021 - 2027, USD Million
TABLE 203 Asia Pacific Hematology Market by Country, 2017 - 2020, USD Million
TABLE 204 Asia Pacific Hematology Market by Country, 2021 - 2027, USD Million
TABLE 205 Asia Pacific Neurology Market by Country, 2017 - 2020, USD Million
TABLE 206 Asia Pacific Neurology Market by Country, 2021 - 2027, USD Million
TABLE 207 Asia Pacific Erythropoietin Drugs Market by Country, 2017 - 2020, USD Million
TABLE 208 Asia Pacific Erythropoietin Drugs Market by Country, 2021 - 2027, USD Million
TABLE 209 China Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 210 China Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 211 China Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 212 China Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 213 China Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 214 China Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 215 China Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 216 China Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 217 Japan Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 218 Japan Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 219 Japan Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 220 Japan Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 221 Japan Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 222 Japan Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 223 Japan Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 224 Japan Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 225 India Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 226 India Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 227 India Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 228 India Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 229 India Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 230 India Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 231 India Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 232 India Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 233 South Korea Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 234 South Korea Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 235 South Korea Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 236 South Korea Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 237 South Korea Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 238 South Korea Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 239 South Korea Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 240 South Korea Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 241 Singapore Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 242 Singapore Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 243 Singapore Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 244 Singapore Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 245 Singapore Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 246 Singapore Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 247 Singapore Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 248 Singapore Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 249 Malaysia Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 250 Malaysia Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 251 Malaysia Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 252 Malaysia Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 253 Malaysia Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 254 Malaysia Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 255 Malaysia Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 256 Malaysia Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 257 Rest of Asia Pacific Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 258 Rest of Asia Pacific Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 259 Rest of Asia Pacific Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 260 Rest of Asia Pacific Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 261 Rest of Asia Pacific Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 262 Rest of Asia Pacific Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 263 Rest of Asia Pacific Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 264 Rest of Asia Pacific Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 265 LAMEA Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 266 LAMEA Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 267 LAMEA Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 268 LAMEA Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 269 LAMEA Biologics Market by Country, 2017 - 2020, USD Million
TABLE 270 LAMEA Biologics Market by Country, 2021 - 2027, USD Million
TABLE 271 LAMEA Biosimilars Market by Country, 2017 - 2020, USD Million
TABLE 272 LAMEA Biosimilars Market by Country, 2021 - 2027, USD Million
TABLE 273 LAMEA Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 274 LAMEA Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 275 LAMEA Epoetin-alfa Market by Country, 2017 - 2020, USD Million
TABLE 276 LAMEA Epoetin-alfa Market by Country, 2021 - 2027, USD Million
TABLE 277 LAMEA Epoetin-beta Market by Country, 2017 - 2020, USD Million
TABLE 278 LAMEA Epoetin-beta Market by Country, 2021 - 2027, USD Million
TABLE 279 LAMEA Darbepoetin-alfa Market by Country, 2017 - 2020, USD Million
TABLE 280 LAMEA Darbepoetin-alfa Market by Country, 2021 - 2027, USD Million
TABLE 281 LAMEA Other Product Market by Country, 2017 - 2020, USD Million
TABLE 282 LAMEA Other Product Market by Country, 2021 - 2027, USD Million
TABLE 283 LAMEA Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 284 LAMEA Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 285 LAMEA Renal Diseases Market by Country, 2017 - 2020, USD Million
TABLE 286 LAMEA Renal Diseases Market by Country, 2021 - 2027, USD Million
TABLE 287 LAMEA Cancer Market by Country, 2017 - 2020, USD Million
TABLE 288 LAMEA Cancer Market by Country, 2021 - 2027, USD Million
TABLE 289 LAMEA Hematology Market by Country, 2017 - 2020, USD Million
TABLE 290 LAMEA Hematology Market by Country, 2021 - 2027, USD Million
TABLE 291 LAMEA Neurology Market by Country, 2017 - 2020, USD Million
TABLE 292 LAMEA Neurology Market by Country, 2021 - 2027, USD Million
TABLE 293 LAMEA Erythropoietin Drugs Market by Country, 2017 - 2020, USD Million
TABLE 294 LAMEA Erythropoietin Drugs Market by Country, 2021 - 2027, USD Million
TABLE 295 Brazil Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 296 Brazil Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 297 Brazil Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 298 Brazil Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 299 Brazil Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 300 Brazil Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 301 Brazil Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 302 Brazil Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 303 Argentina Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 304 Argentina Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 305 Argentina Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 306 Argentina Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 307 Argentina Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 308 Argentina Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 309 Argentina Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 310 Argentina Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 311 UAE Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 312 UAE Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 313 UAE Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 314 UAE Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 315 UAE Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 316 UAE Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 317 UAE Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 318 UAE Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 319 Saudi Arabia Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 320 Saudi Arabia Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 321 Saudi Arabia Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 322 Saudi Arabia Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 323 Saudi Arabia Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 324 Saudi Arabia Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 325 Saudi Arabia Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 326 Saudi Arabia Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 327 South Africa Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 328 South Africa Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 329 South Africa Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 330 South Africa Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 331 South Africa Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 332 South Africa Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 333 South Africa Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 334 South Africa Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 335 Nigeria Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 336 Nigeria Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 337 Nigeria Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 338 Nigeria Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 339 Nigeria Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 340 Nigeria Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 341 Nigeria Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 342 Nigeria Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 343 Rest of LAMEA Erythropoietin Drugs Market, 2017 - 2020, USD Million
TABLE 344 Rest of LAMEA Erythropoietin Drugs Market, 2021 - 2027, USD Million
TABLE 345 Rest of LAMEA Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
TABLE 346 Rest of LAMEA Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
TABLE 347 Rest of LAMEA Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
TABLE 348 Rest of LAMEA Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
TABLE 349 Rest of LAMEA Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
TABLE 350 Rest of LAMEA Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
TABLE 351 Key information –Johnson and Johnson
TABLE 352 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 353 Key Information – Amgen, Inc.
TABLE 354 key information – F. Hoffmann-La Roche Ltd.
TABLE 355 Key Information – Biocon Limited
TABLE 356 Key Information – Intas Pharmaceutical Ltd.
TABLE 357 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 358 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 359 Key Information – LG Corporation
TABLE 360 key information – Celltrion, Inc.

List of Figures
FIG 1 Methodology for the research